$373 Million is the total value of MPM BioImpact LLC's 37 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 125.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TPTX | Buy | Turning Point Therapeutics, Inc. | $9,434,000 | -27.1% | 351,350 | +29.5% | 2.53% | +7.3% |
| GERN | Buy | Geron Corporation | $8,363,000 | +21.9% | 6,149,277 | +9.3% | 2.24% | +79.4% |
| RETA | New | Reata Pharmaceuticals inc-a | $5,897,000 | – | 180,000 | +100.0% | 1.58% | – |
| ARQT | New | Arcutis Biotherapeutics inc | $4,979,000 | – | 258,500 | +100.0% | 1.34% | – |
| RLMD | New | Relmada Therapeutics inc | $3,725,000 | – | 138,000 | +100.0% | 1.00% | – |
| ACAD | Buy | Acadia Pharmaceuticals Inc | $3,675,000 | +25.9% | 151,750 | +21.4% | 0.99% | +85.3% |
| AVDL | Buy | Avadel Pharmaceuticals Plcadr | $2,816,000 | -7.2% | 412,363 | +9.9% | 0.76% | +36.7% |
| PHAT | New | Phathom Pharmaceuticals inc | $2,631,000 | – | 193,326 | +100.0% | 0.71% | – |
| KRTX | New | Karuna Therapeutics inc | $2,536,000 | – | 20,000 | +100.0% | 0.68% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Harpoon Therapeutics, Inc. | 15 | Q2 2023 | 27.6% |
| Repare Therapeutics, Inc. | 14 | Q3 2023 | 19.7% |
| TCR2 Therapeutics, Inc. | 14 | Q1 2023 | 18.0% |
| iTeos Therapeutics, Inc. | 13 | Q3 2023 | 15.7% |
| G1 Therapeutics, Inc. | 13 | Q4 2022 | 13.3% |
| Y Mabs Therapeutics, Inc. | 12 | Q3 2022 | 5.4% |
| Cullinan Oncology, Inc. | 11 | Q3 2023 | 41.4% |
| Epizyme, Inc. | 11 | Q2 2022 | 22.1% |
| Oncorus, Inc. | 11 | Q2 2023 | 13.3% |
| Intellia Therapeutics, Inc. | 10 | Q3 2023 | 5.5% |
View MPM BioImpact LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| SC 13D/A | 2023-08-01 |
| SC 13D | 2023-06-12 |
| 4 | 2023-06-05 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
View MPM BioImpact LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.